New treatment option for Fractures, Open
Official title The Treatment of Type I Open Fractures in Pediatrics
ClinicalTrials.gov ID: NCT00870064
What this study is testing
- What it's testing
- Open fractures are frequently encountered in orthopaedics. Treatment usually calls for a formal, operative procedure in which the bone is exposed, foreign tissue is debrided and the wound is irrigated.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 3 to 14
You may be able to join if
- open fracture amenable to treatment by closed reduction
- low energy mechanism of injury (e.g., falls from less than 10 feet, bicycle accidents)
- wound less than 1cm in length and the bone not visualized through the skin
You likely can't join if
- open fracture not amenable to treatment by closed reduction
- open fracture that would typically require operative reduction and fixation
- high energy mechanism of injury (e.g., struck by vehicle, motor vehicle accidents, fall from height greater than 10 feet)
- wound greater than 1cm in length
- gross contamination of wound
- open fractures involving hands or feet (the current standard of care to treat open injuries involving hands or feet is only emergency room management)
The study team makes the final eligibility decision.
Where it's taking place
- Chicago, Illinois, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 3 years to 14 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chicago, Illinois, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.